Genfit S.A. (GNFTF)
OTCMKTS · Delayed Price · Currency is USD
3.720
+0.440 (13.41%)
At close: Jul 25, 2025
Genfit Market Cap
Genfit has a market cap or net worth of $211.60 million as of September 18, 2025. Its market cap has increased by 1.42% in one year.
Market Cap
211.60M
Enterprise Value
188.31M
Revenue
73.19M
Ranking
n/a
PE Ratio
135.62
Stock Price
$3.72
Market Cap Chart
Since December 20, 2006, Genfit's market cap has increased from 192.64M to 211.60M, an increase of 9.84%. That is a compound annual growth rate of 0.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 211.60M | 15.95% |
| Dec 31, 2024 | 182.50M | -6.18% |
| Dec 29, 2023 | 194.52M | -7.62% |
| Dec 30, 2022 | 210.57M | -13.73% |
| Dec 31, 2021 | 244.08M | 28.79% |
| Dec 31, 2020 | 189.52M | -75.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Tian'an Technology Group | 792.01M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| Northwest Biotherapeutics | 373.88M |
| CytoDyn | 351.92M |
| American Oncology Network | 345.48M |